Hove Pharma
ActiveSummary
Hove Pharma has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €227,556 and a net result of €51,083. Equity is growing by ~10.4% per year across the filed fiscal years. Its solvency ranks better than 38% of 10522 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 1.4% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability76▲+4
Solvency52▲+3
Growth52=
Track record100
Bankruptcy probability, 12 months
1.4%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13,000 at 30 days acceptable
Liquidity tight (current ratio 1.39 against 1.54 in 2024; short-term debt: 26.6% and cash: 3% of total assets), and 73.2% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
26.8%
Return on assets
6%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
24 d late
2024
12 d late
2023
27 d late
2022
31 d late
2021
22 d late
2020
25 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 24 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 47% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 24 August (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€227,556▲ 19.5%
2024 · €190,473
Total assets
€849,286▲ 5.3%
2024 · €806,526
Net result
€51,083▲ 58.1%
2024 · €32,317
Working capital
€88,054▼ 0.3%
2024 · €88,342
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€102,439▲ 34.5%-€47,269€41,007€53,005▲ 29.3%€78,858▲ 48.8%
Net result€73,218above the sector's middle half▲ 38.9%-€59,044below the sector's middle half€22,547within the sector's middle half€32,317within the sector's middle half▲ 43.3%€51,083within the sector's middle half▲ 58.1%
Equity€205,949above the sector's middle half▲ 55.2%€146,904above the sector's middle half▼ 28.7%€162,157within the sector's middle half▲ 10.4%€190,473within the sector's middle half▲ 17.5%€227,556within the sector's middle half▲ 19.5%
Total assets€680,658above the sector's middle half▲ 6.8%€887,594above the sector's middle half▲ 30.4%€840,334within the sector's middle half▼ 5.3%€806,526within the sector's middle half▼ 4.0%€849,286within the sector's middle half▲ 5.3%
Debt€474,709▼ 6.0%€740,690▲ 56.0%€678,177▼ 8.4%€616,053▼ 9.2%€621,730▲ 0.9%
Working capital€113,450above the sector's middle half▲ 334%€60,774within the sector's middle half▼ 46.4%€56,672within the sector's middle half▼ 6.8%€88,342within the sector's middle half▲ 55.9%€88,054within the sector's middle half▼ 0.3%
Solvency30.3%within the sector's middle half▲ 9.4pp16.6%within the sector's middle half▼ 13.7pp19.3%within the sector's middle half▲ 2.7pp23.6%within the sector's middle half▲ 4.3pp26.8%within the sector's middle half▲ 3.2pp
Current ratio1.47within the sector's middle half▲ 0.361.34within the sector's middle half▼ 0.131.33within the sector's middle half▼ 0.011.54within the sector's middle half▲ 0.211.39within the sector's middle half▼ 0.15
Return on assets (ROA)10.8%within the sector's middle half▲ 2.5pp-6.7%below the sector's middle half▼ 17.4pp2.7%within the sector's middle half▲ 9.3pp4.0%within the sector's middle half▲ 1.3pp6.0%within the sector's middle half▲ 2.0pp
Staff (FTE)1.2▲ 140%1▼ 16.7%0.6below the sector's middle half▼ 40.0%0.6below the sector's middle half=1below the sector's middle half▲ 66.7%
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2022 the operating result has climbed three years in a row; 2025 is 49% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €849,286
Fixed assets
€534,898 ▼ 3.7%
Current assets
€314,388 ▲ 25.2%
Equity and liabilities €849,286
Equity
€227,556 ▲ 19.5%
Debt
€621,730 ▲ 0.9%
Debt's share of the balance-sheet total falls from 76.4% to 73.2%. Equity and debt are higher.
Key figures and ratios
EBITDA
€141,487▲
2024 · €113,724
Cash flow
€113,711▲
2024 · €93,036
Quick ratio
0.70▲
2024 · 0.69
Debt to equity
2.73▼
2024 · 3.23
ROE
22.4%▲
2024 · 17.0%
Interest coverage
9.43▲
2024 · 5.82
Debt ≤ 1 year
€226,334▲
2024 · €162,735
Debt > 1 year
€393,332▼
2024 · €450,439
Income taxes
€13,179▲
2024 · €1,685
Staff costs
€56,990▲
2024 · €29,143
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,713 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.
- Micro
- 5 to 10 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.8%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 1.4% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,713 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €28,362 | €27,062 | €28,592 | €29,143 | €56,990 | ▲ 95.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €48,611 | €99,172 | €62,613 | €60,719 | €62,628 | ▲ 3.1% |
| Other operating charges640/8 | €674 | €1,183 | €381 | €600 | €338 | ▼ 43.7% |
| Non-recurring operating charges66A | - | €1,417 | €0 | - | - | - |
| Gross operating margin9900 | €180,085 | €81,566 | €132,594 | €143,467 | €198,814 | ▲ 38.6% |
| Operating profit (loss)9901 | €102,439 | -€47,269 | €41,007 | €53,005 | €78,858 | ▲ 48.8% |
| Financial income75/76B | - | €179 | €308 | €544 | €409 | ▼ 24.9% |
| Recurring financial income75 | - | €179 | €308 | €544 | €409 | ▼ 24.9% |
| Financial charges65/66B | €8,362 | €11,830 | €18,769 | €19,548 | €15,005 | ▼ 23.2% |
| Recurring financial charges65 | €8,362 | €11,830 | €18,769 | €19,548 | €15,005 | ▼ 23.2% |
| Profit (loss) for the period before taxes9903 | €94,077 | -€58,920 | €22,547 | €34,001 | €64,262 | ▲ 89.0% |
| Income taxes67/77 | €20,859 | €125 | €0 | €1,685 | €13,179 | ▲ 682% |
| Profit (loss) for the period9904 | €73,218 | -€59,044 | €22,547 | €32,317 | €51,083 | ▲ 58.1% |
| Profit (loss) for the period to be appropriated9905 | €73,218 | -€59,044 | €22,547 | €32,317 | €51,083 | ▲ 58.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €680,658 | €887,594 | €840,334 | €806,526 | €849,286 | ▲ 5.3% |
| Fixed assets21/28 | €327,780 | €650,652 | €612,432 | €555,450 | €534,898 | ▼ 3.7% |
| Intangible fixed assets21 | €228,000 | €199,500 | €171,000 | €142,500 | €114,000 | ▼ 20.0% |
| Tangible fixed assets22/27 | €94,530 | €451,152 | €441,432 | €412,950 | €420,898 | ▲ 1.9% |
| Land and buildings22 | - | €382,576 | €362,976 | €343,376 | €323,776 | ▼ 5.7% |
| Plant, machinery and equipment23 | €80,213 | €67,427 | €78,456 | €69,574 | €57,218 | ▼ 17.8% |
| Furniture and vehicles24 | €14,317 | €1,150 | €0 | - | - | - |
| Other tangible fixed assets26 | - | - | - | - | €39,904 | - |
| Financial fixed assets28 | €5,250 | €0 | - | - | - | - |
| Current assets29/58 | €352,878 | €236,942 | €227,902 | €251,076 | €314,388 | ▲ 25.2% |
| Stocks and contracts in progress3 | €113,963 | €107,858 | €127,509 | €139,579 | €156,493 | ▲ 12.1% |
| Stocks30/36 | €113,963 | €107,858 | €127,509 | €139,579 | €156,493 | ▲ 12.1% |
| Amounts receivable within one year40/41 | €53,975 | €95,634 | €82,706 | €96,769 | €130,171 | ▲ 34.5% |
| Trade receivables40 | €53,975 | €71,559 | €73,232 | €71,669 | €95,005 | ▲ 32.6% |
| Other amounts receivable41 | - | €24,075 | €9,474 | €25,100 | €35,165 | ▲ 40.1% |
| Cash at bank and in hand54/58 | €181,203 | €31,643 | €15,485 | €12,735 | €25,326 | ▲ 98.9% |
| Deferred charges and accrued income490/1 | €3,737 | €1,808 | €2,202 | €1,993 | €2,398 | ▲ 20.3% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €680,658 | €887,594 | €840,334 | €806,526 | €849,286 | ▲ 5.3% |
| Equity10/15 | €205,949 | €146,904 | €162,157 | €190,473 | €227,556 | ▲ 19.5% |
| Contributions10/11 | €80,000 | €80,000 | €80,000 | €80,000 | €80,000 | = |
| Reserves13 | €125,949 | €66,904 | €82,157 | €110,473 | €147,556 | ▲ 33.6% |
| Distributable reserves133 | €125,949 | €66,904 | €82,157 | €110,473 | €147,556 | ▲ 33.6% |
| Profit (loss) carried forward14 | - | - | €0 | €0 | €0 | - |
| Amounts payable17/49 | €474,709 | €740,690 | €678,177 | €616,053 | €621,730 | ▲ 0.9% |
| Amounts payable after more than one year17 | €232,114 | €562,867 | €506,947 | €450,439 | €393,332 | ▼ 12.7% |
| Financial debts170/4 | €232,114 | €562,867 | €506,947 | €450,439 | €393,332 | ▼ 12.7% |
| Amounts payable within one year42/48 | €239,428 | €176,168 | €171,230 | €162,735 | €226,334 | ▲ 39.1% |
| Current portion of amounts payable after more than one year42 | €31,264 | €55,342 | €55,920 | €56,508 | €57,108 | ▲ 1.1% |
| Trade debts44 | €90,344 | €95,857 | €102,969 | €98,151 | €144,347 | ▲ 47.1% |
| Suppliers440/4 | €90,344 | €95,857 | €102,969 | €98,151 | €144,347 | ▲ 47.1% |
| Taxes, remuneration and social security45 | €41,990 | €24,969 | €4,809 | €4,075 | €7,730 | ▲ 89.7% |
| Taxes450/3 | €38,428 | €20,984 | €401 | €0 | €197 | - |
| Remuneration and social security454/9 | €3,562 | €3,985 | €4,409 | €4,075 | €7,533 | ▲ 84.8% |
| Other amounts payable47/48 | €75,831 | €0 | €7,532 | €4,000 | €17,150 | ▲ 329% |
| Accrued charges and deferred income492/3 | €3,166 | €1,656 | €0 | €2,879 | €2,064 | ▼ 28.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €73,218 | -€59,044 | €22,547 | €32,317 | €51,083 | ▲ 58.1% |
| + Depreciation and write-downs630 | €48,611 | €99,172 | €62,613 | €60,719 | €62,628 | ▲ 3.1% |
| Operating cash flow (approximation) | €121,828 | €40,128 | €85,160 | €93,036 | €113,711 | ▲ 22.2% |
| Investment in fixed assets (approximation) | - | -€422,045 | -€24,393 | -€3,737 | -€42,076 | ▼ 1,026% |
| Change in cash | - | -€149,560 | -€16,158 | -€2,750 | €12,591 | ▲ 558% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
24-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 24 days late
2025
31-12
Financial
Equity above €200,000Eq €227,556 ▲19.5%
3 profitable years in a row build equity to €227,556.
12-08
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema · 12 days late
2024
27-08
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema · 27 days late
2023
31-12
Financial
Back to profitnet €22,547
Net result €22,547 after one loss-making year.
31-12
Financial
Equity above €150,000Eq €162,157 ▲10.4%
Equity rises from €146,904 to €162,157.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Weakest financial yearnet -€59,044
Net result drops to -€59,044, the lowest in the series; recovery starts the following year.
22-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 22 days late
2021
31-12
Financial
Highest result since 2020net €73,218 ▲38.9%
Operating result €102,439, net result €73,218, both a record.
31-12
Financial
Equity above €200,000Eq €205,949 ▲55.2%
2 profitable years in a row build equity to €205,949.
25-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 25 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hove · 1 establishment unit since 2020
Ground area
665 m²
Building footprint
232 m²
Volume, LiDAR
1,841 m³
Parcel 11021A0048/00P002, Flanders · tallest building 11.6 m, ±3 floors. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Hove Pharma
since 20202.296.010.487
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11021A0048/00P002 | Flanders | 665 m² | 1 · 232 m² | 11.6 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Food safety, FASFC
1 siteHove2.296.010.487
Similar companies · same sector, comparable size
PHARMATOUNE
BE 0878.532.562
Beersel · Eq €227,518
MAXIPHARMA
BE 0460.509.874
Charleroi · Eq €227,467
PHARMACIE CHATELLE
BE 0506.720.179
Sint-Lambrechts-Woluwe · Eq €227,664
APOTHEEK AMERY
BE 0425.481.590
Nieuwpoort · Eq €227,240
APOTHEEK GRIETJE PAEME
BE 0829.837.275
Brussel · Eq €227,236
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,545 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded18-11-2019
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
Contact
Website
www.hovepharma.be
E-invoicing
Reachable via Peppol
Peppol ID
0208:0737798331
Also
9925:BE0737798331
Registered
21-11-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.